OPC-12759 Ophthalmic suspension

DRUG4 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd.

Conditions

Dry Eye SyndromesKeratoconjunctival Epithelial Disorder

Phase 1

Safety Study of OPC-12759 Ophthalmic Solution

CompletedNCT01471093

Otsuka Pharmaceutical Co., Ltd.Dry Eye Syndromes

Start: 2011-11-30End: 2012-02-29Updated: 2021-06-29

Phase 2

Exploratory Study of OPC-12759 Ophthalmic Suspension

CompletedNCT01493180

Otsuka Pharmaceutical Co., Ltd.Keratoconjunctival Epithelial Disorder

Start: 2011-12-31End: 2012-12-31Updated: 2015-03-10

Phase 3

Long Term Administration Study of OPC-12759 Ophthalmic Suspension

CompletedNCT00818324

Otsuka Pharmaceutical Co., Ltd.Dry Eye Syndromes

Start: 2009-01-31End: 2011-01-31Updated: 2014-02-26

Confirmatory Study of OPC-12759 Ophthalmic Suspension

CompletedNCT00885079

Otsuka Pharmaceutical Co., Ltd.Dry Eye Syndromes

Start: 2009-05-31End: 2010-04-30Updated: 2013-12-12